Xvivo Perfusion AB (publ) (STO: XVIVO)

Market Cap	16.79B
Revenue (ttm)	698.73M
Net Income (ttm)	120.74M
Shares Out	31.50M
EPS (ttm)	3.93
PE Ratio	135.79
Forward PE	125.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,942
Open	530.00
Previous Close	530.00
Day's Range	525.00 - 535.00
52-Week Range	205.50 - 547.00
Beta	2.09
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden, the United States, the Netherlands, Italy, North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a c...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 160
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: XVIVO

Financial Performance

In 2023, XVIVO's revenue was 597.54 million, an increase of 43.88% compared to the previous year's 415.29 million. Earnings were 91.82 million, an increase of 398.29%.